Pharmaceutical Technology

JULY 6, 2022

Business optimism improved in June 2022 compared to May 2022, even amid concerns over rising costs and slowing demand, revealed an analysis of an ongoing poll by Verdict. Business confidence remains equivalent to long-term average in the UK. The East of England reported the highest increase in business confidence from 14% to 31%.

52

52

BuzzRx

FEBRUARY 13, 2023

The AmazonSmile program has been criticized for donating only a small percentage (50 cents on a $100 purchase) to charity. However, those seemingly small donations made a big difference for thousands of nonprofit organizations and have left many concerned about finding ways to replace the funding. How is your business giving back?

Packaging 98

Packaging 98

Pharmaceutical Technology

SEPTEMBER 9, 2022

US-based biotech company Gatehouse Bio is extending its collaboration with AstraZeneca for developing RNA therapeutics to treat heart failure with preserved ejection fraction (HFpEF). It is expected to expedite the development of a wide range of new therapeutics using the small non-coding area of the genome that is not explored.

Compounding 98

Compounding 98

DiversifyRx

APRIL 22, 2024

Moneyball is a fantastic movie on so many levels, and my business brain can’t help but glean pharmacy business lessons each time I watch it. A business (The A’s) was vastly outgunned by competitors (other MLB teams) with massive budgets. Billy teaches us this in the movie. Let me translate for you.

Independent Pharmacies 52

Independent Pharmacies 52

pharmaphorum

FEBRUARY 12, 2021

Rory Mullen, head of biopharma at Ireland’s economic development agency IDA Ireland tells pharmaphorum why business is blossoming in the Emerald Isle. Now we are seeing foreign and direct investment all over Ireland and Ireland is a small country! Ireland looks East. However, attracting Asian investment has not been easy, says Mullen.

Packaging 121

Packaging Pharmaceutical Companies Pharmaceutical Companies 121

European Pharmaceutical Review

FEBRUARY 21, 2023

Good manufacturing practice registration was one of the hardest lifts I’ve had in my 30 years of building businesses. Where there are small, technical standards to think through – whether with the Home Office, MHRA or NHS – we will be happy to provide our views and support the growth of the sector. He founded Celadon in 2018.

Pharmaceutical Companies 130

Pharmaceutical Companies Pharmaceutical Companies Compounding 130

Pharmaceutical Technology

AUGUST 12, 2022

The US Food and Drug Administration (FDA) has granted approval for Daiichi Sankyo and AstraZeneca ’s Enhertu (fam-trastuzumab deruxtecan-nxki) to treat unresectable or metastatic non-small cell lung cancer (NSCLC) in adults.

FDA 105

FDA Chemotherapy 105

STAT

SEPTEMBER 22, 2022

A dank cloudy cover greeted us this morning, but we are ignoring the gloom by keeping busy. So please join us as we fortify ourselves with more cups of stimulation — we are back to blueberry cobbler — and get started. Hello, everyone, and how are you today? After all, there is much to be done.

80

80

pharmaphorum

JANUARY 11, 2023

However, the ‘Big Data paradigm’ is not so much concerned with the volume of that data, but how businesses and, indeed, industries can derive meaningful insights from what has become a glut of information. From Big Data to small. Over the past few decades, data generation has veritably exploded. This is where problems arise. “In

Compounding 115

Compounding 115

Pharmaceutical Technology

MARCH 10, 2023

The US Food and Drug Administration (FDA) has granted approval for Pfizer ’s Zavzpret (zavegepant) for the acute treatment of migraine in adult patients with or without aura. Zavzpret is claimed to be the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray approved to treat migraine.

FDA 98

FDA 98

pharmaphorum

AUGUST 10, 2021

“As a small innovative company, we cannot afford to wait it out,” he said, while in the US there is a “clear path to reimbursement.” At the time, the biotech said it would also reduce staff and restructure its European business in order to focus on “priority” markets.

FDA 135

FDA 135

European Pharmaceutical Review

OCTOBER 27, 2022

The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) has released new data on the US bioscience industry, indicating it was valued at $2.9 The report also found that in 2021, the US industry employed 2.1 million people in over 127,000 businesses. trillion dollars in 2021.

Vaccines 94

Vaccines Compounding 94

Pharmaceutical Technology

AUGUST 11, 2022

The merged company is expected to be named Disc Medicine, which will have corporate headquarters in Watertown, Massachusetts, US. The proceeds from the business combination will be utilised to advance the pipeline of Disc to clinical trials and offer funding into 2025. To back the merger, Disc raised funds worth $53.5m

59

59

Fuld

JANUARY 31, 2022

The past two years have been a time of profound disruption and change which has impacted us all on many different levels. Beginning today, Tuesday 1st February, you can access our Business and Industry Research , Data Analytics , and Financial, Equity and M&A Research desks.

52

52

STAT

JULY 26, 2023

As for us, we are as busy as ever hunting and gathering items of interest. So join us as we hoist the ever-present cup of stimulation and attack the to-do list. We trust you have your own hectic agendas. Our choice today is cinnamon hazelnut. Meanwhile, have a grand day, everyone, and do stay in touch.

73

73

pharmaphorum

OCTOBER 26, 2022

But Giacomo Chiesi, head of Chiesi Global Rare Diseases, thinks of his 6,000-person company as a family business. And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. Caring for a global community.

Patient Care 76

Patient Care FDA 76

pharmaphorum

JANUARY 20, 2022

To create efficiencies in the overall process, they should likewise evaluate how long approval and dissemination take within their business compared to industry norms. “If A small to medium company may be interested in efficiency across the board. Then you’ve got the FDA in the US, ADPI in the UK, ANSM in France.

Communication 98

Communication FDA Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

JULY 7, 2023

Specifically, the reports “provide crucial insights into the needs, challenges and opportunities of these important sectors and the scope for industry, academia and government to work together to boost their productivity and drive economic growth,” according to Professor Francisco Veloso, Dean of Imperial College Business School.

Compounding 87

Compounding Pharmaceutical Companies Pharmaceutical Companies 87

Pharmaceutical Technology

JULY 1, 2022

The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects. Ayvakit has received the US Food and Drug Administration (FDA) approval to treat advanced systemic mastocytosis in adults.

FDA 59

FDA 59

pharmaphorum

APRIL 28, 2022

For instance, according to the US Government Accountability Office , 30 million Americans have a rare disease, a little less than 10% of the population. But the company was inspired to re-brand its rare disease business unit as a response to internal ramp-ups that have occurred over the last few years, Helfgott said.

Pharmaceutical Companies 58

Pharmaceutical Companies Pharmaceutical Companies Immunization 58

pharmaphorum

DECEMBER 8, 2022

Currently working with regulators and policy makers to expand the population that can be given its Covid vaccine, Novavax recently received MHRA approval of a heterologous booster, yet is waiting to present to and receive JCVI approval, too, with over 1 million doses delivered and ready to go.

Vaccines 88

Vaccines 88

Pharmaceutical Technology

DECEMBER 29, 2022

It has also been authorised to treat unresectable, advanced or recurrent non-small cell lung cancer (NSCLC) along with chemotherapy. It has also been approved in Japan, EU, China, the US, as well as in many other countries to treat extensive-stage small cell lung cancer (ES-SCLC).

Chemotherapy 52

Chemotherapy 52

pharmaphorum

APRIL 30, 2021

Human papillomavirus vaccine Gardasil was hit particularly hard, slumping 16% to $917 million thanks to “headwinds related to the rollout of COVID vaccines in adults” in the US and the timing of shipments to China. Pipeline-boosting deals looming? The company has already taken some recent steps in that direction with the $1.85

Vaccines 65

Vaccines FDA Immunization 65

pharmaphorum

NOVEMBER 20, 2022

. “Holmes understood that at best it could only perform a few basic tests and was slower than existing devices, said the US Department of Justice. “She knew that it could not successfully compete with the established conventional machines.” “I regret my failings with every cell of my body,” she continued. .

FDA 106

FDA 106

pharmaphorum

JANUARY 23, 2023

Takeda has taken rights outside China, Hong Kong and Macau to Hutchmed’s colorectal cancer therapy fruquintinib , a small molecule vascular endothelial growth factor receptors (VEGFR) 1, 2 and 3 taken as a once daily pill that is in late-stage development in the US, Europe and Japan with filings due later this year.

FDA 52

FDA 52

pharmaphorum

MAY 18, 2022

The US pharma group is paying $47 million in upfront payments to license rights to the undisclosed drug outside China, Hong Kong, Macao, and Taiwan, with another $1.36 billion in potential milestone payments plus royalties on sales. Kelun Pharma said that the deal would accelerate its entry into international markets.

58

58

Pharmaceutical Technology

NOVEMBER 13, 2022

The US Food and Drug Administration (FDA) has granted approval for AstraZeneca ’s Imfinzi (durvalumab) plus Imjudo (tremelimumab) and platinum-based chemotherapy to treat Stage IV (metastatic) non-small cell lung cancer (NSCLC) in adults.

FDA 52

FDA Chemotherapy Labelling Immunization 52

pharmaphorum

JULY 1, 2022

Sixth Street is paying the biotech $250 million upfront for a share of future royalties on Ayvakit and follow-up BLU-263, in a deal that also provides up to $660 million in credit facilities that can be used for business development. Blueprint is drawing $150 million of that straight away. billion if needed.

52

52

pharmaphorum

DECEMBER 2, 2020

Both in their mid-twenties, the two men set up what was initially a fine chemicals business in a Brooklyn factory, using a loan from Pfizer’s father as capital. Pfizer was founded in 1849 by two recent German immigrants to the USA, Charles Pfizer and Charles Erhart. The era of mega-mergers.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

Pharmaceutical Technology

AUGUST 3, 2022

Olutasidenib, an investigational agent, is an oral, small molecule inhibitor of mutant isocitrate dehydrogenase 1 (mIDH1) that attaches to and hinders mutated IDH1 enzymes. According to the latest exclusive, global agreement, Forma is entitled to get $2m in upfront payments. and tiered royalty payments.

FDA 59

FDA 59

pharmaphorum

MARCH 23, 2022

Whether you’re a large pharma company or a small, emerging one, communication is key. Large pharma vs small pharma: differences in digital strategy. Attendees will leave with a better understanding of digital healthcare communication and some best practices for using those insights to improve their own strategies.

Communication 102

Communication Pharmaceutical Companies Pharmaceutical Companies 102

European Pharmaceutical Review

FEBRUARY 22, 2023

“Today’s approval offers physicians and patients in the EU more flexibility to determine the right treatment plan and enables more patients to potentially benefit from this medicine,” explained Dave Fredrickson, Executive Vice President of AstraZeneca’s Oncology Business Unit.

86

86

pharmaphorum

SEPTEMBER 29, 2021

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. In this column he addresses the appropriate use of email and how to avoid nightmares in electronic communication.

Communication 111

Communication 111

European Pharmaceutical Review

DECEMBER 6, 2022

An analysis of GlobalData’s Pharmaceutical Intelligence Center Drugs Database revealed that despite a drop in sales of COVID-19 antibody, REGEN-COV, due to ineffectiveness against Omicron variant, Regeneron experienced record US sales of $1.63 billion in Q3 from its eye disease drug Eylea. GSK and Sanofi’s share prices dropped sharply by 46.4

Vaccines 77

Vaccines FDA 77

Pharma Marketing Network

SEPTEMBER 28, 2020

Six months after the Covid -19 pandemic upended health, personal, and economic life for millions around the world, the importance of good, even great leadership in business settings has taken on new dimensions. The world of pharma—and every other business imaginable—initially experienced shock, confusion, and no small amount of anxiety.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

SEPTEMBER 28, 2020

Six months after the Covid -19 pandemic upended health, personal, and economic life for millions around the world, the importance of good, even great leadership in business settings has taken on new dimensions. The world of pharma—and every other business imaginable—initially experienced shock, confusion, and no small amount of anxiety.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

JUNE 7, 2023

Member Spotlight: Thomas Carganico Trudy Patterson Wed, 06/07/2023 - 10:31 iSpeak Blog iSpeak Member Spotlight: Thomas Carganico Edyna Miguez 7 June 2023 Since 2013, Thomas Carganico has worked extensively within the pharmaceutical services industries across the US, UK, and Europe. How has ISPE helped advance your career?

Communication 94

Communication 94